Hologic, Inc. (Nasdaq: HOLX) is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products dedicated to serving the healthcare needs of women throughout the world.
At Hologic, we are on a mission: to help women everywhere lead longer, healthier lives. It is our reason for being and the single focus of every breakthrough we pursue, every solution we design, every investment we make.
Hologic is the leader in ten areas of women's health including: mammography and breast biopsy; radiation treatment for early-stage breast cancer; breast MRI, cervical cancer screening; treatment for menorrhagia and uterine fibroids; permanent contraception; osteoporosis assessment; preterm birth risk assessment; mini C-arms for extremity imaging; as well as molecular diagnostic products, including human papillomavirus (HPV) testing and reagents for a variety of DNA analysis applications. We offer clinicians the tools they need to spot cancer or osteoporosis while they can still do something about it. And treat the whole woman at every stage of her life, not just the disease.
We are proud of this achievement and conscious of the responsibility that our leadership position brings with it. We believe that the health issues facing women today deserve and demand the singular dedication of a passionate company.
Our core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health.